RNU6-857P

Across TCGA pan-cancer cohorts, RNU6-857P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RNU6-857P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RNU6-857P RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RNU6-857P expression acts as an unfavorable survival marker, although some lineages such as ESCA and CESC show a favorable association.

ESCA, SKCM, and LAML are the cancer types where RNU6-857P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	DFS	Quartile	III,IV	0.497	0.261	.029	51	view →
SKCM	OS	Tertile	III,IV	0.406	0.717	.001	45	view →
LAML	DFS	Tertile	All	0.028	0.572	<.001	36	view →
TGCT	DFS	Tertile	All	0.067	0.802	.001	18	view →
KIRC	DFS	Tertile	All	0.405	0.664	.002	18	view →
UCS	DFS	Tertile	III,IV	0.153	0.439	.049	18	view →
PCPG	DFS	Tertile	All	0.161	0.819	.004	18	view →
LIHC	DFS	Tertile	All	0.167	0.546	.007	18	view →
BRCA	DFS	Tertile	All	0.721	0.903	.038	12	view →
CESC	DFS	Tertile	All	0.857	0.714	.026	12	view →
LUSC	OS	Tertile	All	0.835	0.661	.016	12	view →
MESO	OS	Tertile	III,IV	0.258	0.583	.037	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RNU6-857P–ESCA (DFS)

Open the ESCA breakdown →